BORGESON BLAKE sold 0.5% of their position (30K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $97.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2026ACC: 0001856094-26-000014
Director
Since Apr 2021
-30K
Net shares
Net seller
$97.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−30K
Price / share
$3.25
Trade value
$97.50K
% of position
0.5%
8/4/2026
6.22M→6.19M
Total
Net shares
−30K
Net value
-$97.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/4/2026 | S · Sale | −30K | $3.25 | $97.50K | 0.5% | 6.22M | 6.19M |
| Total | −30K | -$97.50K | ||||||
Derivative Transactions0
No derivative transactions reported